Gynecologic oncology reports

Gynecol Oncol Rep · ISSN (print) 2352-5789 · 186 papers in corpus
case-report 2024
doi:10.1016/j.gore.2024.101394 ·PMID:38646445

Clear cell carcinoma is a rare and very aggressive subset of cervical cancer, with poor outcome if diagnosed at advanced stage. There are few data available on the optimal management of this histotype, and treatment recommendations that inc…

case-report 2023
doi:10.1016/j.gore.2023.101145 ·PMID:36818196

•Research surrounding treatment of leiomyosarcoma (LMS) treatment remains sparse.•Pembrolizumab/lenvatinib has been reported as a therapy for endometrial cancer, though not yet as therapy for LMS.•This report demonstrates disease regression…

case-report 2023
doi:10.1016/j.gore.2023.101139 ·PMID:36747897

When a woman presents with an acute abdomen with cystic lesions in the abdominal cavity, the differential diagnosis includes torsion or rupture of an ovarian tumor. We report our experience with a 54-year-old nulliparous woman who underwent…

case-report 2023
doi:10.1016/j.gore.2023.101237 ·PMID:37449085

Patients with advanced stage or recurrent mucinous ovarian carcinoma exhibit poor response to standard platinum- and taxane-based chemotherapy and poor prognosis. We report a 29-year-old patient with recurrent ERBB2-amplified mucinous ovari…

case-report 2023
doi:10.1016/j.gore.2023.101199 ·PMID:37251786

OBJECTIVE: Endometrial cancer is the most common gynecological malignancy in the United States. Despite the high prevalence amongst cisgender females the prevalence of this gynecological malignancy in transgender men has not been clearly id…

other 2023
doi:10.1016/j.gore.2023.101213 ·PMID:37397238
case-report 2023
doi:10.1016/j.gore.2023.101165 ·PMID:36968297

•Ichthyosis uteri is a rare condition describing extensive endometrial keratinization.•There may be an association with squamous cell carcinoma of the endometrium.•Endometrial extension of cervical malignancy may closely resemble ichthyosis…

observational 2023
doi:10.1016/j.gore.2023.101292 ·PMID:37868015

BACKGROUND: Literature evaluating the management of abnormal uterine bleeding in premenopausal patients prior to endometrial malignancy diagnosis is lacking. OBJECTIVE: To evaluate predictors and consequences of inadequate evaluation and m…

other 2023
doi:10.1016/j.gore.2023.101314 ·PMID:38192506
case-report 2023
doi:10.1016/j.gore.2023.101225 ·PMID:37415960

•This 71 year old patient was diagnosed with mixed squamous and clear cell ovarian adenocarcinoma.•Patient was surgically staged with guidance from frozen section.•Patient received adjuvant treatment with carboplatin and paclitaxel for 6 cy…

case-report 2023
doi:10.1016/j.gore.2023.101168 ·PMID:37006448

•Mixed GTN.•GTN in a post-menopausal woman.•Treatment of GTN with immunotherapy.

case-report 2023
doi:10.1016/j.gore.2023.101283 ·PMID:37860082

Clear cell carcinoma (CCC) of the vulva is extremely rare. We report a case of a 54-year-old woman who presented with a 5 cm mass of the mons pubis. She underwent needle biopsy demonstrating CCC. She then underwent radical vulvectomy with b…

case-report 2023
doi:10.1016/j.gore.2023.101212 ·PMID:37293350

While Non-Hodgkin Lymphoma (NHL) often involves the ovaries at time of autopsy, it is rarely present at the time of diagnosis. Here we present a case of a 20-year-old who presented with a large adnexal mass and elevated B-HCG, CA-125, and L…

case-report 2023
doi:10.1016/j.gore.2023.101181 ·PMID:37077325
case-report 2023
doi:10.1016/j.gore.2023.101195 ·PMID:37215243

BACKGROUND: Extraovarian primary peritoneal carcinoma (EOPPC) is a rare form of epithelial adenocarcinoma arising from the peritoneal lining with little to no ovarian involvement. To date, very few cases of EOPPC with primary tumors outside…

case-report 2023
doi:10.1016/j.gore.2023.101305 ·PMID:38033359

Clear cell carcinomas are rare and relatively chemo-insensitive ovarian cancers with a characteristic molecular pathogenesis. Alterations in ARID1A, a component of the multiprotein chromatin remodeling complex SWI/SNF, are likely early even…

observational 2023
doi:10.1016/j.gore.2023.101140 ·PMID:36714374

OBJECTIVE: The COVID-19 vaccine is known to instigate an inflammatory response that impacts cancer testing. We aimed to evaluate carbohydrate antigen 125 (CA-125) trends in gynecologic oncology patients in surveillance following COVID-19 va…

observational 2023
doi:10.1016/j.gore.2023.101175 ·PMID:37091214

Ovarian cancer is taken as the most typical malignancy among women and the ninth most typical cancer in Iran. Predictive tools are of great importance as ovarian cancer is usually detected in patients at later stages of the disease. In othe…

other 2023
doi:10.1016/j.gore.2023.101143 ·PMID:36845024

Social media outlets have increased in popularity within the last decade and are influencing the ways in which patients interact with the healthcare system. The objective of this study is to examine the presence of gynecologic oncology divi…

case-report 2023
doi:10.1016/j.gore.2023.101222 ·PMID:37576356

Total Laparoscopic hysterectomy is most commonly performed under general anesthesia. In elderly patients with severe medical co-morbidities and endometrial malignancy, laparoscopic surgery under general anesthesia can be hazardous. In such …

case-report 2023
doi:10.1016/j.gore.2023.101192 ·PMID:37131341

Squamous cell carcinoma of the ovary (SCC) is a rare and aggressive disease and optimal treatment is unknown. Here we report the case of a 29- year-old woman who presented with abdominal pain and was ultimately found to have a multi-septate…

observational 2022
doi:10.1016/j.gore.2022.101017 ·PMID:35754560

OBJECTIVE: The microbiome of the female upper reproductive tract (URT) has not been characterized. We hypothesize that distinct bacterial species may be identified in different areas of the URT in women with or without ovarian cancers. MET…

case-report 2022
doi:10.1016/j.gore.2022.100995 ·PMID:35574241

Abdominal wall endometriosis with subsequent transformation to clear cell carcinoma is quite rare. The pathogenesis and pattern of this transformation is not well known; hence evaluation and management guidelines are not well established. W…

observational 2022
doi:10.1016/j.gore.2021.100913 ·PMID:35005157

OBJECTIVE: To examine clinicopathologic characteristics and oncologic outcomes of patients diagnosed with Mullerian adenosarcoma and to evaluate ovarian preservation as a practical management option in early-stage disease. METHODS: A retro…

case-report 2022
doi:10.1016/j.gore.2022.101010 ·PMID:35663849

•Immune checkpoint inhibitors can be safely administered to patients with dermatomyositis.•Immunosuppressants did not impact the efficacy of treatment with an immune check point inhibitor.•Patients with autoimmune disorders who require immu…